Harm Jan Bogaard — Amsterdam UMC research portal

View Scopus Profile

Research activity per year

If you made any changes in Pure these will be visible here soon.

1 Finished

SYMptom monitoring with Patient-Reported Outcomes using a web application among LUNG cancer patients in the Netherlands
Billingy, N., Becker - Commissaris, A., Tromp, V., Walraven, I., van den Hurk, C., Hugtenburg, J., Bogaard, H. J., Onwuteaka-Philipsen, B., Aaronson, N. K., van de Poll-Franse, L. & Belderbos, J.
1/10/2019 → 30/09/2022
Project: Research

244 Article
50 Meeting Abstract
29 Review article
12 Comment / Letter to the editor
More

90-Day Clinical Outcome of Hospitalized Covid-19 Patients Treated with Imatinib
Schippers, J., Duijvelaar, E., Smeele, P., De Raaf, M., Blok, S., Vanhove, A., De Man, F., Bogaard, H. J. & Aman, J., 1 May 2022, In: American Journal of Respiratory and Critical Care Medicine. 205
Research output: Contribution to Journal › Meeting Abstract › Academic
A New Clinical Phenotype with Non-Plexiform Vasculopathy and Distinctive Microvessel Remodeling Among Idiopathic Pulmonary Arterial Hypertension Patients
Nossent, E. J., Smits, J., Seegers, C., Meijboom, L., Boonstra, A., Tran-Lundmark, K., Aman, J., De Man, F., Bogaard, H., Radonic, T., Dorfmueller, P. & Noordegraaf, A. V., 1 May 2022, In: American Journal of Respiratory and Critical Care Medicine. 205, D96.
Research output: Contribution to Journal › Meeting Abstract › Academic
ARDS in the time of corona: context and perspective
Voelkel, N. F., Bogaard, H. J. & Kuebler, W. M., 1 Oct 2022, In: American journal of physiology. Lung cellular and molecular physiology. 323, 4, p. L431-L437
Research output: Contribution to Journal › Editorial › Academic › peer-review
A systematic review with meta-analysis of biomarkers for detection of pulmonary arterial hypertension
Smits, A. J., Botros, L., Mol, M. A. E., Ziesemer, K. A., Wilkins, M. R., Noordegraaf, A. V., Bogaard, H. J. & Aman, J., 1 Apr 2022, In: ERJ open research. 8, 2, 00009-2022.
Research output: Contribution to Journal › Review article › Academic › peer-review

Open Access
Cardiac Safety of Imatinib for the Treatment of COVID-19: A Secondary Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial
CounterCOVID Collaborative Group, 28 Dec 2022, In: Journal of cardiovascular pharmacology. 80, 6, p. 783-791 9 p.
Research output: Contribution to journal › Article › Academic › peer-review

1 Citation (Scopus)